Bionomics Gross Profit vs. Shares Owned By Insiders

BNOX Stock  USD 0.30  0.01  3.45%   
Based on Bionomics' profitability indicators, Bionomics Ltd ADR may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Bionomics' ability to earn profits and add value for shareholders.
 
Gross Profit  
First Reported
2000-09-30
Previous Quarter
-436.3 K
Current Value
-5.2 M
Quarterly Volatility
1.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Bionomics' Price To Sales Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to rise to 7,348 in 2024, despite the fact that Operating Cash Flow Sales Ratio is likely to grow to (776.53). At this time, Bionomics' Total Other Income Expense Net is fairly stable compared to the past year. Net Interest Income is likely to rise to about 231.1 K in 2024, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (1.9 M).
For Bionomics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bionomics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bionomics Ltd ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bionomics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bionomics Ltd ADR over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionomics. If investors know Bionomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.19)
Revenue Per Share
0.072
Quarterly Revenue Growth
0.093
Return On Assets
(0.40)
Return On Equity
(0.78)
The market value of Bionomics ADR is measured differently than its book value, which is the value of Bionomics that is recorded on the company's balance sheet. Investors also form their own opinion of Bionomics' value that differs from its market value or its book value, called intrinsic value, which is Bionomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionomics' market value can be influenced by many factors that don't directly affect Bionomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bionomics ADR Shares Owned By Insiders vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bionomics's current stock value. Our valuation model uses many indicators to compare Bionomics value to that of its competitors to determine the firm's financial worth.
Bionomics Ltd ADR is rated fourth in gross profit category among its peers. It is number one stock in shares owned by insiders category among its peers . At this time, Bionomics' Gross Profit is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bionomics' earnings, one of the primary drivers of an investment's value.

Bionomics Shares Owned By Insiders vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Bionomics

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
(18.96 M)
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Bionomics

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
33.91 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Bionomics Shares Owned By Insiders Comparison

Bionomics is currently under evaluation in shares owned by insiders category among its peers.

Bionomics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bionomics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bionomics will eventually generate negative long term returns. The profitability progress is the general direction of Bionomics' change in net profit over the period of time. It can combine multiple indicators of Bionomics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-2 M-1.9 M
Operating Income-17.9 B-17 B
Income Before Tax-10.3 M-10.8 M
Total Other Income Expense Net17.9 B18.8 B
Net Loss-15.5 M-14.7 M
Income Tax Expense-87.3 M-83 M
Net Interest Income220.1 K231.1 K
Interest Income220.1 K186.4 K
Net Loss-15.5 M-16.3 M
Net Loss-28.7 M-27.2 M
Change To Netincome2.7 M2.9 M
Net Loss-1.6 K-1.5 K
Income Quality 0.95  0.66 
Net Income Per E B T1.5 K1.6 K

Bionomics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bionomics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bionomics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bionomics' important profitability drivers and their relationship over time.

Use Bionomics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionomics will appreciate offsetting losses from the drop in the long position's value.

Bionomics Pair Trading

Bionomics Ltd ADR Pair Trading Analysis

The ability to find closely correlated positions to Bionomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionomics Ltd ADR to buy it.
The correlation of Bionomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionomics ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bionomics position

In addition to having Bionomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Energy ETFs Thematic Idea Now

Energy ETFs
Energy ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 91 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.